Ovarian, colorectal, and pancreatic cancer markers plus metabolic risk factors
The short answer
Women's Cancer Screening Panel bundles 12 tests — CA-125 (Ovarian Cancer Marker), AFP (Alpha-Fetoprotein) and CEA (Carcinoembryonic Antigen) plus 9 more — for $299.99 plus one $6 lab processing fee (about $25.00 per test). Fast 8–12 hours before the draw; results post in 3–5 business days. Physician-authorized with no doctor's visit or insurance needed; one draw at Quest or Labcorp.
Other Labs
Starting at $600
+ lab fees
TestWell
$299.99
+ $6 lab processing fee
The Women's Cancer Screening Panel combines direct tumor markers with metabolic indicators linked to cancer risk. CA-125 screens for ovarian cancer — elevated levels can indicate ovarian malignancy, endometriosis, or other pelvic conditions. CEA screens for colorectal cancer, CA 19-9 for pancreatic cancer, and AFP for liver cancer. These are complemented by metabolic markers — elevated insulin and IGF-1 are associated with increased cancer risk, LDH is elevated in many cancers, hs-CRP measures systemic inflammation linked to cancer progression, and ferritin can be elevated in certain malignancies. CBC and CMP provide baseline blood health and organ function context. This panel is not diagnostic — it is a screening tool best used as part of regular preventive care.
Women's cancer screening biomarkers: CA-125 (ovarian), CA 15-3 (breast), CA 19-9 (pancreatic/GI), CEA (colorectal/general), FIT Test (colon), CBC, LDH. Surveillance panel for women 40+ with risk factors.
Women 50+ for routine cancer surveillance, women 40+ with family history (especially BRCA1/2 carriers), women with persistent unexplained symptoms, survivors monitoring for recurrence. Not a substitute for mammogram, Pap smear, or colonoscopy.
Sample Type
Blood draw
Fasting
Required
Results In
3–5 business days · typical; varies by lab and draw day
Biomarkers
38 across 12 tests
12 individual tests · 38 biomarkers measured — each test linked so you can learn more.
Fasting for 8–12 hours is recommended. Inform your provider if you are menstruating, pregnant, or have known endometriosis, as these can affect CA-125 levels.
What can throw off this result
Physician-reviewed “Before your test” pages — what each factor does, for how long, and what to do about it.
A Women's Cancer Screening Panel costs $299.99 at TestWell — $305.99 all-in, since the $6 lab processing fee is charged once per order and there is no draw or physician fee. With insurance you pay your plan's negotiated rate against your deductible; TestWell's price is fixed before the draw and HSA/FSA-eligible.
| Where you order | Price | One test, all-in | Notes |
|---|---|---|---|
| TestWell (drawn at Quest or Labcorp) | $299.99 | $305.99 | Includes the one $6 lab processing fee, charged once per order |
Competitor prices are read from the linked public pages and re-checked regularly; the labs' sites may add taxes or change prices without notice.
Compare more: Quest Diagnostics price list · Labcorp price list · Quest vs Labcorp · Lab test price checker
USPSTF specifically recommends AGAINST routine CA-125 in average-risk women — too many false positives. Most useful for women with known BRCA mutations or strong family history, monitoring known ovarian cancer, or evaluating a pelvic mass with imaging. See the CA-125 test page for details.
No. Mammogram remains the gold standard for breast cancer screening (CA 15-3 is for monitoring known disease, not screening). Pap smear / HPV testing remains the gold standard for cervical cancer screening (no blood test substitute exists). This panel adds tumor markers that complement, but don't replace, imaging and cytology screening.
On TestWell, the Women's Cancer Screening Panel is $299.99. Ordering the same tests separately would be about $400. Quest Health lists comparable bundles at $600, walk-in hospital labs typically bill $1500-2500 without insurance.
Most mildly elevated tumor markers in average-risk women are false positives — CA-125 can be elevated by endometriosis, fibroids, even menstruation. A single elevated result usually needs repeat at 4-6 weeks before any imaging workup. Don't panic at borderline results.
Annually for women 50+ or women with BRCA mutations / strong family history. Less frequently if all markers have been stable. Always pair with mammogram, Pap smear, and colonoscopy on age-appropriate schedule.
Some cancers leave measurable traces in blood, but no routine blood test detects cancer in general. Tumor markers such as CA-125 (ovarian), CA 15-3 and CA 27.29 (breast), CEA (colorectal and others) and CA 19-9 (pancreatic) are used mainly to monitor known cancers and treatment response; as screening tests they miss early disease and rise for benign reasons, so a normal result does not rule cancer out and an abnormal one does not diagnose it. A CBC and metabolic panel can show indirect clues — anemia, abnormal liver values — that prompt imaging. Screening that is proven to save lives (mammography, Pap/HPV, colonoscopy or FIT, low-dose CT for smokers) is imaging or tissue-based, not a blood draw.
Women with a personal or strong family history of ovarian or breast cancer who are working with a clinician and want a baseline, and women already diagnosed who are tracking markers between visits. It is not a substitute for age-appropriate screening, and an elevated marker should always be followed up with a clinician rather than acted on alone. Newer multi-cancer early-detection blood tests exist but are not part of this panel and are not yet recommended for routine screening.
Women's Cancer Screening Panel results are typically ready in 3–5 business days after your draw at Quest or Labcorp. TestWell emails you the moment they post, and your results dashboard shows each marker against its reference range with a plain-English explanation.
Peptides and GLP-1s, prednisone and other corticosteroids and exercise can change a Women's Cancer Screening Panel result without anything being wrong. Peptides and GLP-1s can lower Hemoglobin A1c and can raise BUN, IGF-1 and Insulin — expected treatment effect — A1c is the monitoring marker, not a reason to stop. Prednisone and other corticosteroids can raise Glucose and WBC and can lower Lymphocytes, hs-CRP and Potassium — expected on steroids; A1c over weeks reflects it. Exercise can raise ALT and Creatinine and 2 more markers on this test — rest 48 hours before a liver panel. Each is explained on our physician-reviewed "Before your test" pages; when one applies, remove it and retest.
Order the Women's Cancer Screening Panel online from TestWell for $299.99 (plus a $6 per-order lab processing fee) — no doctor's visit, referral or insurance needed. A licensed physician authorizes the order, then you walk into any Quest or Labcorp patient service center near you for the draw (the lab locator on our site lists the closest ones by ZIP code), and results arrive in 3–5 business days.
Medically reviewed by Youmna DiStefano, MD · Last reviewed September 2026
Starting at $600 at other labs
TestWell Price
$299.99
+ $6 lab processing fee at checkout
No insurance needed · HIPAA compliant
Individual tests that complement this panel
Women's Cancer Screening Panel
$299.99